Neoadjuvant Chemo Benefits Some Variant MIBC Patients
Researchers find prolonged survival among patients with neuroendocrine muscle-invasive bladder cancer.
Researchers find prolonged survival among patients with neuroendocrine muscle-invasive bladder cancer.
The document spells out in greater detail the criteria for radical and partial nephrectomy and for placing patients on active surveillance.
Median overall survival was 9.3 months longer for black versus white patients with metastatic castration-resistant prostate cancer.
Lowest quartile of serum testosterone is associated with 48% and 65% increased odds of stress and mixed urinary incontinence, respectively.
In a study, 81.1% of men were able to void after an average of 28 days after treatment.
The cumulative incidence of venous thromboembolism following radical cystectomy was nearly 6.7% over 10 years.
Use of continent diversion procedures peaked in 2008, and has been decreasing since.
Nomogram based on a cohort of men with high-risk prostate cancer is more accurate than the CAPRA and MSKCC nomograms, researchers report.
In a study, 86% of prostatic urethral lift patients experienced symptom relief in the first month.
Each 10 mg/dL increase in total cholesterol is associated with a significant 23% greater odds of high-grade prostate cancer.